Heterogeneity in Metastatic Breast Cancer (18)F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?

Yazar: Kurland, Brenda F., Oesterreich, Steffi
Yayımlandı J Nucl Med (2018)

Letter to the Editor Response to CCR-16-0362R: Authors’ reply

Yazar: Kurland, Brenda F., Linden, Hannah M., Mankoff, David A.
Yayımlandı Clin Cancer Res (2017)

Nondaily Smokers’ Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical Trial

Yazar: Shiffman, Saul, Kurland, Brenda F., Scholl, Sarah M., Mao, Jason M.
Yayımlandı JAMA Psychiatry (2018)

Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?

Yazar: Shiffman, Saul, Mao, Jason M., Kurland, Brenda F., Scholl, Sarah M.
Yayımlandı Psychopharmacology (Berl) (2018)

Longitudinal Data with Follow-up Truncated by Death: Match the Analysis Method to Research Aims

Yazar: Kurland, Brenda F., Johnson, Laura L., Egleston, Brian L., Diehr, Paula H.
Baskı/Yayın Bilgisi 2009

Design considerations for using PET as a response measure in single- and multi-center clinical trials

Yazar: Doot, Robert K., Kurland, Brenda F., Kinahan, Paul E., Mankoff, David A.
Baskı/Yayın Bilgisi 2011

Acquired resistance to the Hsp90 inhibitor, ganetespib in KRAS mutant NSCLC is mediated via reactivation of the ERK–p90RSK–mTOR signaling network

Yazar: Chatterjee, Suman, Huang, Eric H.-B., Christie, Ian, Kurland, Brenda F., Burns, Timothy F.
Yayımlandı Mol Cancer Ther (2017)

Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years

Yazar: Syrjala, Karen L., Kurland, Brenda F., Abrams, Janet R., Sanders, Jean E., Heiman, Julia R.
Baskı/Yayın Bilgisi 2008

Multicenter trials using FDG PET to predict chemotherapy response : Effects of differential measurement error and bias on power calculations for unselected and enrichment designs

Yazar: Kurland, Brenda F, Doot, Robert K, Linden, Hannah M, Mankoff, David A, Kinahan, Paul E
Baskı/Yayın Bilgisi 2013

Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer

Yazar: Stabile, Laura P., Farooqui, Mariya, Kanterewicz, Beatriz, Abberbock, Shira, Kurland, Brenda F., Diergaarde, Brenda, Siegfried, Jill M.
Yayımlandı J Thorac Oncol (2017)

DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence

Yazar: Wu, Shandong, Zuley, Margarita L., Berg, Wendie A., Kurland, Brenda F., Jankowitz, Rachel C., Sumkin, Jules H., Gur, David
Yayımlandı Sci Rep (2017)

Whole‐Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α‐18F‐Fluoro‐17β‐Estradiol Positron Emission Tomography: Meta‐Analysis and Recommendation...

Yazar: Kurland, Brenda F., Wiggins, Jay R., Coche, Amandine, Fontan, Charlotte, Bouvet, Yann, Webner, Peter, Divgi, Chaitanya, Linden, Hannah M.
Yayımlandı Oncologist (2020)

Factors influencing the uptake of (18)F-Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer

Yazar: Peterson, Lanell M, Kurland, Brenda F, Link, Jeanne M, Schubert, Erin K, Stekhova, Svetlana, Linden, Hannah M, Mankoff, David A
Baskı/Yayın Bilgisi 2011

Prospective Neurocognitive Function Over 5 Years After Allogeneic Hematopoietic Cell Transplantation for Cancer Survivors Compared With Matched Controls at 5 Years

Yazar: Syrjala, Karen L., Artherholt, Samantha B., Kurland, Brenda F., Langer, Shelby L., Roth-Roemer, Sari, Elrod, JoAnn Broeckel, Dikmen, Sureyya
Baskı/Yayın Bilgisi 2011

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium

Yazar: Pidala, Joseph, Kurland, Brenda F., Chai, Xiaoyu, Vogelsang, Georgia, Weisdorf, Daniel J., Pavletic, Steven, Cutler, Corey, Majhail, Navneet, Lee, Stephanie J.
Baskı/Yayın Bilgisi 2011

Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer

Yazar: Wu, Shandong, Berg, Wendie A., Zuley, Margarita L., Kurland, Brenda F., Jankowitz, Rachel C., Nishikawa, Robert, Gur, David, Sumkin, Jules H.
Yayımlandı Breast Cancer Res (2016)

Preclinical immunoPET imaging of glioblastoma-infiltrating myeloid cells using Zirconium-89-labeled anti-CD11b antibody

Yazar: Nigam, Shubhanchi, McCarl, Lauren, Kumar, Rajeev, Edinger, Robert S., Kurland, Brenda F., Anderson, Carolyn J., Panigrahy, Ashok, Kohanbash, Gary, Edwards, W. Barry
Yayımlandı Mol Imaging Biol (2020)

Dynamic and Static Approaches to Quantifying (18)F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Yazar: Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Muzi, Mark, Peterson, Lanell M., Kinahan, Paul E., Kurland, Brenda F., Mankoff, David A.
Baskı/Yayın Bilgisi 2007

Multicenter clinical trials using (18)F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size

Yazar: Kurland, Brenda F, Muzi, Mark, Peterson, Lanell M, Doot, Robert K, Wangerin, Kristen A, Mankoff, David A, Linden, Hannah M, Kinahan, Paul E
Yayımlandı J Nucl Med (2015)

Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma

Yazar: Choi, Jaeyeon, Beaino, Wissam, Fecek, Ronald J., Fabian, Kellsye P.L., Laymon, Charles M., Kurland, Brenda F., Storkus, Walter J., Anderson, Carolyn J.
Yayımlandı J Nucl Med (2018)